Trinity Health Ann Arbor has achieved a medical milestone in the Midwest. The hospital has successfully implanted a next-generation leadless pacemaker, marking a first in the region. This procedure is part of a clinical study to evaluate advancements in cardiac pacing technology.

The study has been granted a FDA Investigational Device Exemption. The goal of the technology is to improve the natural functioning of the heart's chambers. Further details about the study and the procedure are available from Trinity Health Ann Arbor, including comments from the medical director of the Electrophysiology Lab.